CeriBell, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2022-09-29: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-04-22; Total offering amount $102,517,774.
- 2021-05-07: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-04-22; Total offering amount $52,517,785.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2022-09-29 D/A | Rule 506(b) | Equity | 2021-04-22 | $102,517,774 | $102,517,774 | $0 | 17 |
| 2021-05-07 | Rule 506(b) | Equity | 2021-04-22 | $52,517,785 | $52,517,785 | $0 | 14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |